Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statement
KW Davidson, MJ Barry, CM Mangione, M Cabana… - Jama, 2021 - jamanetwork.com
Importance An estimated 13% of all US adults (18 years or older) have diabetes, and 34.5%
meet criteria for prediabetes. The prevalences of prediabetes and diabetes are higher in …
meet criteria for prediabetes. The prevalences of prediabetes and diabetes are higher in …
Screening for type 2 diabetes mellitus
N Peer, Y Balakrishna, S Durao - Cochrane Database of …, 2020 - cochranelibrary.com
Background Diabetes mellitus, a metabolic disorder characterised by hyperglycaemia and
associated with a heavy burden of microvascular and macrovascular complications …
associated with a heavy burden of microvascular and macrovascular complications …
[HTML][HTML] Classification and diagnosis of diabetes
SM Genuth, JP Palmer, DM Nathan - 2021 - europepmc.org
The classification of diabetes was originally limited to only two categories called juvenile-
onset diabetes mellitus, now known as type 1 diabetes mellitus, and adult-onset diabetes …
onset diabetes mellitus, now known as type 1 diabetes mellitus, and adult-onset diabetes …
Screening for prediabetes and type 2 diabetes: updated evidence report and systematic review for the US Preventive Services Task Force
DE Jonas, K Crotty, JDY Yun, JC Middleton, C Feltner… - Jama, 2021 - jamanetwork.com
Importance Type 2 diabetes is common and is a leading cause of morbidity and disability.
Objective To review the evidence on screening for prediabetes and diabetes to inform the …
Objective To review the evidence on screening for prediabetes and diabetes to inform the …
Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch study of intensive …
OBJECTIVE To estimate the benefits of screening and early treatment of type 2 diabetes
compared with no screening and late treatment using a simulation model with data from the …
compared with no screening and late treatment using a simulation model with data from the …
Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial
RK Simmons, JB Echouffo-Tcheugui, SJ Sharp… - The Lancet, 2012 - thelancet.com
Background The increasing prevalence of type 2 diabetes poses a major public health
challenge. Population-based screening and early treatment for type 2 diabetes could reduce …
challenge. Population-based screening and early treatment for type 2 diabetes could reduce …
Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in …
RK Simmons, SJ Griffin, T Lauritzen, A Sandbæk - Diabetologia, 2017 - Springer
Aims/hypothesis There is continuing debate about the net benefits of population screening
for type 2 diabetes. We compared the risk of cardiovascular disease (CVD) and mortality …
for type 2 diabetes. We compared the risk of cardiovascular disease (CVD) and mortality …
Screening for diabetes and prediabetes
D Duan, AP Kengne… - … and Metabolism Clinics, 2021 - endo.theclinics.com
Despite significant progress, screening for type 2 diabetes mellitus (T2DM) remains
controversial, with a lack of uniform recommendation across professional organizations. 1–3 …
controversial, with a lack of uniform recommendation across professional organizations. 1–3 …
A non-invasive risk score including skin autofluorescence predicts diabetes risk in the general population
HE Boersma, MM van der Klauw, AJ Smit… - Scientific reports, 2022 - nature.com
Increased skin autofluorescence (SAF) predicts the development of diabetes-related
complications and cardiovascular disease. We assessed the performance of a simple model …
complications and cardiovascular disease. We assessed the performance of a simple model …
[图书][B] What is the effectiveness of systematic population-level screening programmes for reducing the burden of cardiovascular diseases?
CU Eriksen, O Rotar, U Toft, T Jørgensen - 2021 - apps.who.int
Cardiovascular diseases ( CVDs) remain the main cause of death in the WHO European
Region. This systematic literature review assesses whether systematic screening …
Region. This systematic literature review assesses whether systematic screening …